Total Returns (Price + Dividend) 
Clinitech Lab for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Unaudited Standalone & Consolidated Financial Results For The Half Year Ended September 30 2026
13-Nov-2026 | Source : BSEOutcome of Board Meeting held on Friday November 13 2026 at 12.00 Noon through video conferencing for approval of unaudited Standalone & Consolidated Financial Results for the half year ended September 30 2026
Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulations 2015
13-Nov-2026 | Source : BSEDeclaration of Statement of deviation or variation under Regulation 32 of SEBI (LODR) Regulations 2015
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E On Friday November 13 2026 At 12.00 Noon (IST) Through Video Conferencing
13-Nov-2026 | Source : BSEWe hereby inform that the Board of Directors of the company at its meeting held today i.e. November 13 2026 have:
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 1 FIIs (0.32%)
Jagdish Umakant Nayak (32.08%)
Santosh Gopalkrishna Kudva (5.84%)
32.75%
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 22.12% vs 1.96% in Mar 2025
Growth in half year ended Sep 2025 is 76.47% vs -22.73% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 28.59% vs 0.79% in Mar 2024
YoY Growth in year ended Mar 2025 is 5.41% vs -39.34% in Mar 2024